| Key Financial Ratios of Cohance Lifesciences (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
10.67 |
11.97 |
16.99 |
21.92 |
12.12 |
|
| Diluted EPS (Rs.) |
10.62 |
11.97 |
16.99 |
21.92 |
12.12 |
|
| Cash EPS (Rs.) |
12.92 |
13.89 |
18.68 |
23.46 |
13.37 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
90.95 |
80.76 |
68.72 |
59.74 |
41.84 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
90.95 |
80.76 |
68.72 |
59.74 |
41.84 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
6.00 |
5.00 |
2.00 |
|
| Revenue from Operations/Share (Rs.) |
42.95 |
40.26 |
52.25 |
51.86 |
39.66 |
|
| PBDIT/Share (Rs.) |
16.36 |
18.27 |
24.65 |
30.16 |
17.86 |
|
| PBIT/Share (Rs.) |
14.11 |
16.35 |
22.97 |
28.62 |
16.62 |
|
| PBT/Share (Rs.) |
13.80 |
16.06 |
22.76 |
28.38 |
16.26 |
|
| Net Profit/Share (Rs.) |
10.67 |
11.97 |
16.99 |
21.92 |
12.12 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
38.09 |
45.36 |
47.18 |
58.15 |
45.03 |
|
| PBIT Margin (%) |
32.86 |
40.60 |
43.96 |
55.19 |
41.90 |
|
| PBT Margin (%) |
32.13 |
39.88 |
43.56 |
54.72 |
40.99 |
|
| Net Profit Margin (%) |
24.84 |
29.73 |
32.52 |
42.27 |
30.56 |
|
| Return on Networth / Equity (%) |
11.73 |
14.82 |
24.72 |
36.70 |
28.97 |
|
| Return on Capital Employed (%) |
15.13 |
19.49 |
32.41 |
45.65 |
37.14 |
|
| Return on Assets (%) |
10.49 |
13.60 |
22.09 |
30.92 |
22.71 |
|
| Total Debt/Equity (X) |
0.03 |
0.02 |
0.04 |
0.06 |
0.13 |
|
| Asset Turnover Ratio (%) |
0.45 |
0.49 |
0.71 |
0.83 |
0.82 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.32 |
11.47 |
6.19 |
5.31 |
2.57 |
|
| Quick Ratio (X) |
2.60 |
9.38 |
4.17 |
3.95 |
1.65 |
|
| Inventory Turnover Ratio (X) |
5.84 |
0.93 |
1.42 |
1.90 |
1.65 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
47.07 |
18.24 |
8.24 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
42.83 |
17.05 |
7.48 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
52.93 |
81.76 |
91.76 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
57.17 |
82.95 |
92.52 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
29,575.89 |
17,240.86 |
12,056.22 |
15,793.47 |
12,742.82 |
|
| EV/Net Operating Revenue (X) |
27.05 |
16.82 |
9.06 |
11.96 |
12.62 |
|
| EV/EBITDA (X) |
71.00 |
37.08 |
19.21 |
20.57 |
28.02 |
|
| MarketCap/Net Operating Revenue (X) |
27.00 |
16.80 |
9.05 |
11.92 |
12.49 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
52.92 |
81.75 |
91.75 |
|
| Price/BV (X) |
12.75 |
8.38 |
6.88 |
10.34 |
11.84 |
|
| Price/Net Operating Revenue |
27.00 |
16.80 |
9.05 |
11.92 |
12.49 |
|
| Earnings Yield |
0.01 |
0.02 |
0.04 |
0.04 |
0.02 |
|
Source : Dion Global Solutions Limited
